HSBC Holdings
ICPT

HSBC Holdings’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

HSBC Holdings’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,900
Closed -$462K – 2611
2017
Q4 		$462K Sell
7,900
-100
-1% -$6.31K ﹤0.01% 1535
2017
Q3 		$464K Buy
+8,000
New +$862K ﹤0.01% 1749

HSBC Holdings's ICPT Position: Q4 2023 in Review

HSBC Holdings sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2023, closing a stake of 456,623 shares — an estimated $8.48M sold.

HSBC Holdings first reported a position in ICPT in Q1 2015 and held it in 7 quarters. The position peaked at $8.48M in Q3 2023. 0 funds tracked by Wall St. Rank hold ICPT as of Q4 2023.

  • HSBC Holdings reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
  • HSBC Holdings sold 456,623 Intercept Pharmaceuticals, Inc. shares in Q4 2023, an estimated $8.48M.
  • HSBC Holdings first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2015 and held it in 7 quarters.
  • HSBC Holdings's Intercept Pharmaceuticals, Inc. position peaked at $8.48M in Q3 2023.
  • 0 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2023.

Based on HSBC Holdings's 13F filing for Q4 2023, filed 12 Feb 2024.